Healthcare provider profile · identity verified

David S Page, MD

Family Practice · MIAMISBURG, OH · NPI 1407834153

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1190	318
Amlodipine Besylate	Amlodipine Besylate	871	232
Levothyroxine Sodium	Levothyroxine Sodium	820	209
Lisinopril	Lisinopril	485	144
Omeprazole	Omeprazole	450	138
Losartan Potassium	Losartan Potassium	386	110
Gabapentin	Gabapentin	363	96
Metformin Hcl Er	Metformin Hcl	331	101
Furosemide	Furosemide	311	80
Pantoprazole Sodium	Pantoprazole Sodium	302	87
Sertraline Hcl	Sertraline Hcl	297	75
Rosuvastatin Calcium	Rosuvastatin Calcium	287	97
Carvedilol	Carvedilol	233	55
Hydrochlorothiazide	Hydrochlorothiazide	227	66
Pravastatin Sodium	Pravastatin Sodium	225	59
Tamsulosin Hcl	Tamsulosin Hcl	221	64
Metoprolol Succinate	Metoprolol Succinate	220	66
Montelukast Sodium	Montelukast Sodium	202	69
Potassium Chloride	Potassium Chloride	197	64
Metformin Hcl	Metformin Hcl	190	53
Buspirone Hcl	Buspirone Hcl	187	51
Ezetimibe	Ezetimibe	183	54
Fluticasone Propionate	Fluticasone Propionate	162	67
Famotidine	Famotidine	140	42
Albuterol Sulfate Hfa	Albuterol Sulfate	137	58
Escitalopram Oxalate	Escitalopram Oxalate	133	48
Metoprolol Tartrate	Metoprolol Tartrate	129	36
Simvastatin	Simvastatin	128	35
Azelastine Hcl	Azelastine Hcl	112	55
Alendronate Sodium	Alendronate Sodium	103	30
Glimepiride	Glimepiride	102	35
Duloxetine Hcl	Duloxetine Hcl	97	24
Synthroid	Levothyroxine Sodium	97	30
Clopidogrel	Clopidogrel Bisulfate	92	26
Ramipril	Ramipril	91	25
Pioglitazone Hcl	Pioglitazone Hcl	89	25
Raloxifene Hcl	Raloxifene Hcl	82	20
Allopurinol	Allopurinol	81	28
Doxycycline Hyclate	Doxycycline Hyclate	81	73
Trazodone Hcl	Trazodone Hcl	78	25
Eliquis	Apixaban	71	19
Valsartan	Valsartan	64	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	63	12
Spironolactone	Spironolactone	63	16
Warfarin Sodium	Warfarin Sodium	63	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	59	14
Lorazepam	Lorazepam	58	18
Finasteride	Finasteride	55	15
Tramadol Hcl	Tramadol Hcl	53	17
Bupropion Xl	Bupropion Hcl	52	16
Nateglinide	Nateglinide	51	14
Tizanidine Hcl	Tizanidine Hcl	51	16
Donepezil Hcl	Donepezil Hcl	49	11
Jardiance	Empagliflozin	47	13
Klor-Con M20	Potassium Chloride	47	15
Venlafaxine Hcl Er	Venlafaxine Hcl	47	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	11
Methocarbamol	Methocarbamol	46	22
Glipizide Er	Glipizide	45	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	44	12
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	43	11
Farxiga	Dapagliflozin Propanediol	39	suppressed
Ipratropium Bromide	Ipratropium Bromide	38	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	12
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Prednisone	Prednisone	36	18
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	35	suppressed
Januvia	Sitagliptin Phosphate	34	suppressed
Ozempic	Semaglutide	34	suppressed
Irbesartan	Irbesartan	33	suppressed
Lovastatin	Lovastatin	32	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	32	suppressed
Verapamil Er	Verapamil Hcl	32	suppressed
Fenofibrate	Fenofibrate	31	suppressed
Atenolol	Atenolol	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Pregabalin	Pregabalin	28	suppressed
Azithromycin	Azithromycin	27	21
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Lansoprazole	Lansoprazole	27	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Cefdinir	Cefdinir	26	24
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	15
Alprazolam	Alprazolam	25	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Cefuroxime	Cefuroxime Axetil	24	23
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Tradjenta	Linagliptin	23	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Indapamide	Indapamide	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	17
Nystatin	Nystatin	21	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Fluconazole	Fluconazole	19	16
Mometasone Furoate	Mometasone Furoate	19	17
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	19	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	18	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Scopolamine	Scopolamine	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	11
Dutasteride	Dutasteride	17	suppressed
Levofloxacin	Levofloxacin	17	16
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Baclofen	Baclofen	16	suppressed
Methylprednisolone	Methylprednisolone	16	15
Ondansetron Hcl	Ondansetron Hcl	16	11
Zaleplon	Zaleplon	16	suppressed
Amoxicillin	Amoxicillin	15	14
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Diazepam	Diazepam	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Estradiol	Estradiol	14	suppressed
Haloperidol	Haloperidol	14	suppressed
Promethazine Hcl	Promethazine Hcl	14	suppressed
Tiadylt Er	Diltiazem Hcl	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Sucralfate	Sucralfate	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	12
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Glycopyrrolate	Glycopyrrolate	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Colestipol Hcl	Colestipol Hcl	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Klor-Con M10	Potassium Chloride	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error